###begin article-title 0
###xml 26 31 <span type="species:ncbi:9606">Human</span>
Translation Repression in Human Cells by MicroRNA-Induced Gene Silencing Requires RCK/p54
###end article-title 0
###begin article-title 1
Characterizing a Key Player in Micro, but not Small, RNA Interference
###end article-title 1
###begin p 2
###xml 1415 1418 1415 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 272 277 <span type="species:ncbi:9606">human</span>
###xml 910 915 <span type="species:ncbi:9606">human</span>
RNA interference is triggered by double-stranded RNA that is processed into small interfering RNAs (siRNAs) by Dicer enzyme. Endogenously, RNA interference triggers are created from small noncoding RNAs called microRNAs (miRNAs). RNA-induced silencing complexes (RISC) in human cells can be programmed by exogenously introduced siRNA or endogenously expressed miRNA. siRNA-programmed RISC (siRISC) silences expression by cleaving a perfectly complementary target mRNA, whereas miRNA-induced silencing complexes (miRISC) inhibits translation by binding imperfectly matched sequences in the 3' UTR of target mRNA. Both RISCs contain Argonaute2 (Ago2), which catalyzes target mRNA cleavage by siRISC and localizes to cytoplasmic mRNA processing bodies (P-bodies). Here, we show that RCK/p54, a DEAD box helicase, interacts with argonaute proteins, Ago1 and Ago2, in affinity-purified active siRISC or miRISC from human cells; directly interacts with Ago1 and Ago2 in vivo, facilitates formation of P-bodies, and is a general repressor of translation. Disrupting P-bodies by depleting Lsm1 did not affect RCK/p54 interactions with argonaute proteins and its function in miRNA-mediated translation repression. Depletion of RCK/p54 disrupted P-bodies and dispersed Ago2 throughout the cytoplasm but did not significantly affect siRNA-mediated RNA functions of RISC. Depleting RCK/p54 released general, miRNA-induced, and let-7-mediated translational repression. Therefore, we propose that translation repression is mediated by miRISC via RCK/p54 and its specificity is dictated by the miRNA sequence binding multiple copies of miRISC to complementary 3' UTR sites in the target mRNA. These studies also suggest that translation suppression by miRISC does not require P-body structures, and location of miRISC to P-bodies is the consequence of translation repression.
###end p 2
###begin p 3
RCK/p54 plays a critical role in translational repression mediated by miRISC; translation repression by miRISC does not require P-body structures.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b001">1</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b003">3</xref>
###xml 395 396 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b004">4</xref>
###xml 609 610 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b005">5</xref>
###xml 971 972 959 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b006">6</xref>
###xml 1086 1087 1074 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b007">7</xref>
###xml 1089 1090 1077 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b008">8</xref>
###xml 1183 1184 1171 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b006">6</xref>
###xml 1279 1280 1267 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b009">9</xref>
###xml 1282 1284 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b012">12</xref>
###xml 1325 1328 1313 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1441 1443 1429 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b013">13</xref>
###xml 1244 1249 <span type="species:ncbi:9606">human</span>
Small non-coding RNAs play important roles in the posttranscriptional regulation of genes that code for diverse biological functions, e.g., in most metazoan organisms from nematodes to mammals [ 1- 3]. Two classes of such small (approximately 21 nucleotide [nt]) RNAs that have been extensively studied in gene silencing are short interfering RNAs (siRNAs) and microRNAs (miRNAs) (reviewed in [ 4]). Currently, the best known mechanism of gene silencing is RNA interference (RNAi), an evolutionarily conserved process whereby double-stranded RNA induces the sequence-specific degradation of homologous mRNA [ 5]. Long double-stranded RNA and precursors of miRNAs are processed by Dicer enzyme, and siRNAs are assembled into an RNA-induced silencing complex called RISC. The RNAi machinery can also be programmed in cells by introducing duplexes of siRNAs that are assembled into RNA-induced silencing complexes (siRISC) containing Dicer, argonautes, and other proteins [ 6]. Although RNAi has commonly been associated with siRNAs, this process is largely mediated in plants by miRNAs [ 7, 8], and examples of miRNA-mediated RNAi have been found in mammals and viruses (reviewed in [ 6]). Growing evidence indicates that miRNAs are important in human disease, including cancers [ 9- 12]. For example, relatively low levels of let-7 miRNA up-regulate RAS protein in lung cancer cells, demonstrating a possible role of miRNA in tumorigenesis [ 13].
###end p 5
###begin p 6
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b004">4</xref>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b006">6</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b014">14</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b016">16</xref>
###xml 473 475 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b017">17</xref>
###xml 572 574 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b018">18</xref>
Both classes of small RNAs are assembled into silencing complexes that contain Dicer, argonautes, and other proteins [ 4], but they silence gene expression by two different pathways. Upon recognizing complementary mRNA, activated RISC forms an effector complex with the target mRNA [ 6]. Antisense siRNA in activated RISC serves as a guide for Argonaute2 (Ago2) [ 14- 16] to catalyze the cleavage of target mRNA at a site approximately 10 nt from the 5' end of the siRNA [ 17]. Following cleavage, the target mRNA is degraded. Activated RISC, as a multi-turnover enzyme [ 18], is recycled to cleave additional mRNA targets.
###end p 6
###begin p 7
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b019">19</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b022">22</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b004">4</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b019">19</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b024">24</xref>
In the case of miRNAs, they are assembled into miRNA-induced silencing complexes (miRISC) that contain Dicer, argonaute proteins, transactivation-responsive RNA-binding protein [ 19- 22], and other cellular factors [ 4]. This assembly into miRISC has been implicated in miRNA functions [ 19- 24].
###end p 7
###begin p 8
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b002">2</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b025">25</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b018">18</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b026">26</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b027">27</xref>
Whether siRNA-mediated RNAi or miRNA-mediated inhibition of translation is triggered depends largely on the degree of complementarity between the siRNA or miRNA and its mRNA target (reviewed in [ 2, 25]). While both miRNAs and siRNAs must harbor sequences that recognize the target mRNA, miRNAs are generally not fully complementary to the mRNA target. In contrast, siRNA sequences must be completely complementary to the mRNA target cleavage site to efficiently induce cleavage through the RNAi pathway. Interestingly, miRNAs can behave like siRNAs and induce mRNA cleavage when the miRNA sequence is completely complementary to a target mRNA [ 18, 26, 27].
###end p 8
###begin p 9
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b028">28</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b031">31</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b032">32</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b033">33</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b035">35</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b028">28</xref>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b031">31</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b036">36</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b037">37</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b032">32</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b038">38</xref>
###xml 974 976 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b039">39</xref>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b041">41</xref>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b032">32</xref>
###xml 1105 1107 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b033">33</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b038">38</xref>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b029">29</xref>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b031">31</xref>
###xml 3 8 <span type="species:ncbi:9606">human</span>
In human cells, the mechanism by which the endogenous miRNA and siRNA pathways are distinguished is not clearly understood. It is also unclear how miRNAs repress the translation of target mRNAs. New insights into miRNA function have recently been provided by localization of the RISC components, Ago1 and Ago2, in mRNA-processing bodies (P-bodies) [ 28- 31], which are cytoplasmic foci containing translationally repressed mRNP complexes. During cellular translational control, an mRNP complex is formed containing the translationally repressed mRNA and associated repressor proteins and lacking translation initiation factors [ 32]. These translationally repressed mRNPs accumulate in P-bodies and contain proteins that mediate the translation [ 33- 35], RNAi [ 28- 31, 36], translation suppression [ 37], and decay [ 32, 38] of cellular mRNA. P-bodies, also referred to as GW or Dcp bodies, contain GW182 proteins that have recently been reported to play a role in RNAi [ 39- 41]. Other proteins found in cytoplasmic P-bodies and implicated in mRNA processing are RCK/p54, Lsm1, Dcp1:2, and eIF4E [ 32, 33, 38]. Given that target mRNA and RISC components have been co-localized in P-bodies [ 29, 31], it is possible that P-bodies are the bona fide site for RISC-induced target cleavage or repression of translation. However, the mechanism by which target mRNA and miRISC are directed to P-bodies and how translation is repressed by miRISC is still unknown.
###end p 9
###begin p 10
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b042">42</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b033">33</xref>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b043">43</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b044">44</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b045">45</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 50 55 <span type="species:ncbi:4932">yeast</span>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 281 288 <span type="species:ncbi:8355">Xenopus</span>
###xml 441 446 <span type="species:ncbi:4932">yeast</span>
One P-body protein, RCK/p54, the human homolog of yeast Dhh1p, is a member of the ATP-dependent DEAD box helicase family and was originally identified as a proto-oncogene [ 42]. In human cells, RCK/p54 interacts in P-bodies with the translation initiation factor, eIF4E [ 33]. The Xenopus homolog of RCK/p54, Xp54, which interacts with eIF4E and forms RNA-dependent oligomers, represses the translation of mRNA in oocytes and eggs [ 43]. In yeast, Dhh1p interacts with the decapping and deadenylase complex and functions in translational repression [ 44]. Dhh1p has also recently been shown to stimulate translational repression by inhibiting production of the pre-initiation complex [ 45].
###end p 10
###begin p 11
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 126 131 <span type="species:ncbi:9606">human</span>
Here, we show that RCK/p54 interacts with argonaute proteins, Ago1 and Ago2, in affinity-purified active RISC assemblies from human cells programmed with siRNA or endogenous miRNA; directly interacts with Ago1 and Ago2 in vivo, facilitates formation of cytoplasmic P-bodies, and acts as a general repressor of translation. Depletion of RCK/p54 disrupted P-bodies and dispersed Ago2 throughout the cytoplasm. We further show that depletion of RCK/p54 did not significantly affect the RNAi function of RISC, but released general, miRNA-induced and let-7-mediated translational repression. Taken together, our results suggest that RCK/p54 is the effector molecule in miRISC that represses translation and that the specificity of this repression is dictated by the sequence of miRNA binding to complementary sites in the 3' UTR of the target mRNA.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Argonaute Proteins Interact with RCK/p54, a Component of P-Bodies
###end title 13
###begin p 14
###xml 677 685 677 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 859 867 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 952 960 952 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 1064 1072 1064 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
To investigate the mechanism of miRNA-mediated repression of mRNA translation and to determine the interactions of P-body components with the RNAi machinery, we constructed expression vectors for the yellow fluorescent protein (YFP)-tagged P-body proteins, Lsm1, RCK/p54, Dcp2, and eIF4E. These vectors were co-expressed in HeLa cells with Myc-tagged Ago2 and immunopurified using anti-Myc antibodies. The protein composition of isolated complexes was analyzed by immunoblot using antibodies against green fluorescent protein (GFP) or Myc. When total cell extracts (TCE) were analyzed to determine the protein expression efficiencies of the vectors used in these experiments ( Figure 1A, TCE lane), all YFP- and Myc-tagged proteins were expressed. Analysis of immunopurified complexes revealed that Ago1, Dcp2, RCK/p54, and eIF4E formed complexes with Ago2 ( Figure 1A, anti-Myc lane). Control experiments showed that YFP did not co-purify with Ago2 ( Figure 1A). Interestingly, Lsm1 did not co-purify with Ago2, but localized to P-body structures in HeLa cells ( Figure 1B).
###end p 14
###begin p 15
###xml 633 641 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 754 762 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
Since P-bodies contain RNA and proteins, many protein components of P-bodies are likely to be assembled on a common RNA scaffold without forming functional protein-protein interactions. To address this possibility, HeLa cells were transfected with vectors to co-express Myc-Ago2 and the YFP-tagged P-body proteins, Lsm1, RCK/p54, Dcp2, and eIF4E, subjected to RNase A digestion, and immunopurified. Analysis of immunopurified complexes showed that Ago1 and RCK/p54 interactions with Myc-Ago2 were not affected by RNase treatment, whereas the amounts of Dcp2 and eIF4E protein that co-purified with Myc-Ago2 decreased significantly ( Figure 1A, anti-Myc lane). Control experiments analyzing Myc-Ago2 showed that equal amounts of complexes were purified ( Figure 1A, anti-Myc lane). Taken together, these results suggest that Ago1 and RCK/p54 directly interacted with Ago2, whereas Dcp2 and eIF4E interactions with Ago2 were RNA-mediated. These results do not rule out the possibility that Ago1 and RCK/p54 interactions with Ago2 were mediated by adapter protein(s).
###end p 15
###begin p 16
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b032">32</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b033">33</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b038">38</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b028">28</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b031">31</xref>
###xml 633 641 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b032">32</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b033">33</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b038">38</xref>
###xml 851 860 851 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="sg001">Figure S1</xref>
###xml 963 971 963 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 1256 1265 1256 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="sg001">Figure S1</xref>
###xml 1290 1298 1290 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
Cytoplasmic P-bodies contain RCK/p54, Lsm1, Dcp2, and eIF4E [ 32, 33, 38]. To confirm whether these structures also contain Ago2 as recently reported [ 28, 31], we transfected HeLa cells with expression vectors containing YFP-Ago1, CFP (cyan fluorescent protein)-Ago1, YFP-Ago2, and CFP-Ago2. Transiently expressed YFP- and CFP-tagged Ago1 and Ago2 co-localized at specific foci in cytoplasm (unpublished data). To examine the contents of these cytoplasmic foci, HeLa cells were transfected with expression vectors for YFP-Lsm1 and CFP-Ago2, or YFP-RCK/p54 and CFP-Ago2, and visualized 24 h later by confocal microscopy. As shown in Figure 1B, CFP-Ago2 co-localized with YFP-Lsm1 and YFP-RCK/p54, two bona fide P-body proteins [ 32, 33, 38]. In addition, immunofluorescence experiments showed that endogenous Ago2 co-localized with Lsm1 in P-bodies ( Figure S1). Interestingly, over-expressing YFP-RCK/p54 increased the average number of P-bodies in every cell ( Figure 1B, compare a and d). To confirm that the localization of Ago2 and Lsm1 to P-bodies was not the result of over-expression in transiently transfected cells, we immunostained cells with antibodies to endogenous Ago2 and Lsm1 and found that the localization of Ago2 and Lsm1 to P-bodies ( Figure S1) was similar to that in Figure 1B. These results show that Ago2, Lsm1, and RCK/p54 are present in P-bodies.
###end p 16
###begin p 17
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b046">46</xref>
###xml 347 348 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b047">47</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b048">48</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b050">50</xref>
###xml 827 835 825 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 841 842 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">1</xref>
###xml 992 1000 988 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 1291 1293 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b028">28</xref>
To visualize protein-protein interactions in vivo, we used fluorescence resonance energy transfer (FRET) as a probe. In FRET, a fluorescent donor molecule transfers energy via a nonradiative dipole-dipole interaction to an acceptor molecule [ 46]. We used a well-known donor: acceptor fluorescent-protein pair, CFP:YFP, with a Forster distance (R 0) of 4.9 nm [ 47]. To determine whether Ago1 and Ago2 interacted in vivo with each other and with RCK/p54, we measured the FRET efficiency between the donor, CFP-Ago2, and acceptor, YFP-RCK/p54. To do so, we used a method in which the donor signal lost during FRET is restored by deliberately photobleaching the acceptor fluorophore to abolish its capacity as an energy acceptor [ 48- 50]. In cells expressing YFP-RCK/p54 and CFP-Ago2, the FRET efficiency was 21.07% +/- 2.52% ( Figure 1C and 1D). In cells expressing CFP-Ago2 and YFP-Lsm1, FRET efficiency was not significant (1.62% +/- 1.11%), corroborating our immunoprecipitation results ( Figure 1A). Furthermore, cells co-expressing YFP-RCK/p54 and CFP showed no significant FRET efficiency (1.64% +/- 1.28%). Similar to the YFP-RCK/p54 and CFP-Ago2 pair, YFP-Ago1 and CFP-Ago2 showed an efficient FRET (19.61% +/- 4.51%), indicating a direct interaction between Ago1 and Ago2 in vivo [ 28].
###end p 17
###begin p 18
Interestingly, the FRET efficiency between Ago1 and Ago2 decreased to 12.13% +/- 1.6% when we used CFP-Ago1 and YFP-Ago2, indicating that the energy transfer efficiencies were sensitive to the orientation of donor: acceptor pair in the ribonucleoprotein (RNP) complex. Moreover, only moderate energy transfer efficiency (6.41% +/- 1.96%) was seen when YFP-RCK/p54 and CFP-Ago1 were used in FRET experiments, suggesting that this donor: acceptor pair was not as ideally oriented for an efficient energy transfer as the pair CFP-Ago1 and YFP-Ago2. Alternatively, RCK/p54-Ago1-Ago2 is assembled in an RNP complex where the donor: acceptor pair is affected by the location of the probe. Nonetheless, the efficiency of energy transfer was well above the background control (0.99%). As a control experiment, cells co-expressing YFP-Ago1 and CFP showed no significant FRET efficiency (0.99% +/- 0.67%). Taken together, these results indicate that Ago1 and Ago2 directly interact in vivo with each other and with RCK/p54.
###end p 18
###begin title 19
RCK/p54 Is a Component of RISC Containing the Guide Strand of siRNA
###end title 19
###begin p 20
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g002">Figure 2</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b051">51</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b052">52</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b053">53</xref>
###xml 854 862 854 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g002">Figure 2</xref>
###xml 980 988 980 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g002">Figure 2</xref>
###xml 1064 1069 <span type="species:ncbi:9606">human</span>
To determine whether RCK/p54 is recruited into a functional RISC complex containing argonaute proteins or its association with Ago1/Ago2 is merely due to their co-localization in P-bodies, we affinity-purified active RISCs, analyzed their protein composition, and assayed for RISC function ( Figure 2A). siRNA duplexes targeting GFP (siGFP) were synthesized and 3' -biotin moieties were conjugated to the 3' -end of the guide strand. These two duplexes (unmodified siGFP and biotin-modified siGFP) were transfected into HeLa cells, and RISCs were captured by incubating cell extracts with streptavidin-conjugated magnetic beads [ 51, 52]. Beads and supernatants were analyzed for RISC function, i.e., the ability to cleave target mRNA in vitro [ 53]. RISCs primed with siGFP or biotin-modified siGFP guide strands efficiently cleaved their target mRNA ( Figure 2B, lanes 1 and 3), but only biotin-containing RISC purified on streptavidin-magnetic beads showed cleavage activity ( Figure 2B, lanes 2 and 4). These results show that active RISC can be programmed in human cells by biotin-containing guide strands of siRNAs and can be captured on magnetic beads for further analysis.
###end p 20
###begin p 21
###xml 411 419 411 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g002">Figure 2</xref>
###xml 553 561 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 768 776 768 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
To probe the involvement of P-body proteins in this purified active RISC, its protein composition was analyzed by immunoblot using antibodies against Flag tag or endogenous Ago2, RCK/p54, eIF4E, and Lsm1. When the RNAi machinery was primed with biotin-containing siRNAs, Ago1, Ago2, and RCK/p54 were co-purified with RISC; and when the guide strand of siRNA did not contain biotin, RISC did not bind to beads ( Figure 2C). Interestingly, eIF4E did not co-purify with RISC, indicating that the Myc-Ago2 interaction with eIF4E that occurred in P-bodies ( Figure 1A) was RNA-dependent, and eIF4E did not directly interact with Ago2 to assemble into active RISC by the guide strand. The data also show that Lsm1 was not a RISC component, consistent with findings shown in Figure 1A. Together, these results identify a new argonaute-interacting protein, RCK/p54, that is recruited to siRISC.
###end p 21
###begin title 22
RCK/p54 Is a Component of RISC Containing miRNA
###end title 22
###begin p 23
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
###xml 413 421 413 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 515 523 515 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 736 739 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 877 881 877 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
###xml 897 905 897 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 1020 1028 1020 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 1104 1112 1104 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
To determine the functional interactions of RCK/p54 with miRISC, we employed affinity purification of RISC and target mRNA cleavage capabilities of miRISC when the target has perfectly complementary sequences to the miRNAs. Cell extracts containing let-7 miRISC cleaved perfectly matched radiolabeled target mRNA with high efficiencies, whereas a substrate mRNA containing a mismatched sequence was not cleaved ( Figure 3A, lanes 2 and 3). In the absence of extracts, no mRNA cleavage or degradation was detected ( Figure 3A, lane 1). After establishing the functional assay to analyze miRISC, we next affinity-purified miRISC on magnetic beads using anti-Ago2 and anti-RCK/p54 antibodies and assessed the cleavage of perfectly matched let-7 target mRNA by the bead and supernatant phases. miRISCs purified by anti-Ago2 and anti-RCK/p54 antibodies showed efficient cleavage of let-7 target mRNA ( Figure 3A, lanes 7 and 9). Ago2 antibodies captured most of the RISC activity on beads as compared to RCK/p54 antibodies ( Figure 3A, lanes 6-9). Non-specific IgG did not purify miRISC activities on beads ( Figure 3A, lanes 4 and 5). These results demonstrate that RCK/p54 is a component of functional miRISC.
###end p 23
###begin p 24
###xml 238 246 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g002">Figure 2</xref>
###xml 330 332 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 364 367 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b054">54</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b055">55</xref>
###xml 498 501 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
###xml 686 687 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 942 944 942 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 985 988 985 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1013 1021 1013 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 1081 1084 1081 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b054">54</xref>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b055">55</xref>
###xml 1186 1189 1186 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1264 1267 1264 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1303 1311 1303 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 1394 1396 1394 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b054">54</xref>
###xml 1398 1400 1398 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b055">55</xref>
###xml 1418 1419 1418 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1457 1460 1457 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1501 1504 1501 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1570 1571 1570 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1699 1707 1699 1707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 1776 1779 1776 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
To confirm these results, we next used an alternative approach to determine whether RCK/p54 is associated with endogenous RISC programmed by miRISC. RISCs containing miRNA were isolated from HeLa cells by affinity-capture as described in Figure 2A, with the following modifications. To specifically capture endogenous miRISC, 2'- O-methyl (2'- O Me) inhibitors of let-7 miRNA were employed [ 54, 55]. HeLa cytoplasmic extracts expressing Myc-Ago1 and Flag-Ago2 were incubated with 3'-biotinylated- let-7-2'- O-Me inhibitor, which is complementary to the let-7 miRNA, and incubated with streptavidin-conjugated magnetic beads. As a control, cell extracts were treated with the let-7-2'- O-Me inhibitor without 3'-biotinylation. After capture, beads containing miRISCs were washed with lysis buffer and split into two aliquots to determine miRISC function and protein composition. Function was determined by assaying for in vitro cleavage of a 32P-target mRNA that perfectly matched the let-7 sequence. The data in Figure 3B (lanes 1 and 4) show that cell extracts containing active let-7 miRISC cleaved the perfectly matched target mRNA with high efficiencies [ 54, 55]. Incubation with let-7 inhibitors (with or without 3'-biotin) blocked the cleavage activity of let-7 miRISC in supernatant or beads ( Figure 3B, lanes 2-3, and lanes 5-6). These results are consistent with previous reports [ 54, 55] that adding 2'- O-Me oligonucleotides complementary to let-7 abolishes target cleavage activity by let-7 in cell extracts, indicating complete hybridization of the 2'- O-Me probe. Immunoblot analysis of affinity-purified miRISC using anti-Myc, anti-Flag, anti-RCK/p54, and anti-eIF4E antibodies ( Figure 3C) showed that Myc-Ago1, Flag-Ago2, and RCK/p54 were associated with let-7 miRISC. As observed for the active RISC programmed with siRNA, eIF4E did not associate with miRISC. These findings reveal that RCK/p54 is a novel component of endogenous RISC programmed with either siRNA or miRNA.
###end p 24
###begin title 25
Depletion of RCK/p54 Disrupts P-Bodies and Ago2 Localization
###end title 25
###begin p 26
###xml 422 431 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="sg002">Figure S2</xref>
###xml 613 621 613 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g004">Figure 4</xref>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g004">4</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g004">4</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g004">4</xref>
###xml 831 839 831 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g004">Figure 4</xref>
###xml 845 846 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g004">4</xref>
To understand the function and role of RCK/p54 in the RNAi pathway, RCK/p54 was depleted in P-bodies of HeLa cells by siRNA-mediated RNAi. 24 h after transfecting cells with siRNA, real-time quantitative PCR showed that mRNA levels decreased by more than 90% and immunoblot analysis showed that RCK/p54 protein levels decreased significantly without affecting the levels of other P-body proteins including Lsm1 and Ago2 ( Figure S2). The effect of depleting RCK/p54 on localization of Ago2 was next examined by immunofluorescence analysis of HeLa cells expressing Myc-Ago2 and siRNAs against RCK/p54. As shown in Figure 4B, 4C, 4F, and 4G, depleting RCK/p54 disrupted the cellular P-body structures. In these P-body-deficient cells, Ago2 proteins were diffused throughout the cytoplasm and no longer accumulated at specific foci ( Figure 4A and 4E). This cytoplasmic redistribution of Ago2 suggests that its localization to P-bodies is driven in mammalian cells by factors such as RCK/p54.
###end p 26
###begin title 27
Depletion of Lsm1 Disrupts P-Bodies but Does Not Affect RCK/p54 and Ago2 Interactions
###end title 27
###begin p 28
###xml 310 318 310 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 566 574 566 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 731 739 731 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 1050 1058 1050 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
The interactions between the P-body proteins, RCK/p54, and argonautes raised the question whether P-body structures are required for these interactions. To address this question, we disrupted P-body structures by using RNAi against Lsm1, which is a P-body protein that does not associate with RISC as shown in Figure 1. HeLa cells were transfected with siRNA against Lsm1, harvested at 24, 48, and 72 h post-transfection, and TCEs were analyzed by immunoblot. The results show an efficient knockdown of Lsm1 without changing the levels of RCK/p54, Ago2, and GAPDH ( Figure 5A). We next visualized Lsm1 and Ago2 by immunofluorescence using antibodies against Lsm1 and Myc tag and found that Lsm1 and Ago2 co-localized in P-bodies ( Figure 5B). To determine the status of P-body structures and RISC localization in cells after Lsm1 knockdown, Lsm1-depleted cells were analyzed by immunofluorescence. We found that P-body structures were drastically disrupted, Ago2 was diffused throughout the cytoplasm, and Lsm1 and Ago2 were minimally co-localized ( Figure 5B). These results show that P-body structures were drastically disrupted and Ago2 was diffuse throughout the cytoplasm when Lsm1 was depleted by RNAi.
###end p 28
###begin p 29
###xml 553 561 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 718 726 718 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
To determine the effect of P-body disruption on Ago2 and RCK/p54 interactions, we immunopurified Myc-Ago2 and RCK/p54 after Lsm1 knockdown. HeLa cells were transfected for 48 h with Myc-Ago2 and control siRNA or siRNA against Lsm1, TCEs were prepared, and Myc-Ago2 was immunoprecipitated from an aliquot of TCE. TCEs and anti-Myc immunoprecipitation products were analyzed by immunoblot using anti-Myc, anti-RCK/p54, and anti-Lsm1 antibodies. Lsm1 siRNA treatment efficiently depleted Lsm1 protein levels without affecting Myc-Ago2 and RCK/p54 levels ( Figure 5C). Immunoprecipitation using Myc antibodies showed that RCK/p54 interacted with Ago2 and this interaction was not significantly changed by depleting Lsm1 ( Figure 5C). Since P-bodies were disrupted by Lsm1 depletion, these results demonstrate that Ago2 and RCK/p54 interaction does not require P-bodies.
###end p 29
###begin p 30
###xml 582 584 582 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 598 601 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
###xml 865 873 865 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 990 998 990 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 1045 1053 1045 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 1193 1201 1193 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 1273 1276 1273 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1281 1289 1281 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 1403 1406 1403 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1514 1522 1514 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figure 3</xref>
###xml 1537 1545 1537 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 346 352 <span type="species:ncbi:9986">rabbit</span>
###xml 358 364 <span type="species:ncbi:9986">rabbit</span>
###xml 379 385 <span type="species:ncbi:9986">rabbit</span>
Next, we analyzed the target mRNA cleavage activities of affinity-purified miRISC from Lsm1-depleted cell extracts. P-bodies were disrupted in HeLa cells by transfecting them with siRNA against Lsm1, and cytoplasmic extracts were prepared 48 h post-transfection. These HeLa cell extracts were incubated with magnetic protein A beads coupled with rabbit IgG, rabbit anti-Ago2, or rabbit anti-RCK/p54 antibodies to purify miRISC associated with RCK/p54 or Ago2. After immunoprecipitation, RISC activities were analyzed by incubating the supernatant (S) or bead (B) phases with 182-nt 32P-cap-labeled let-7 substrate mRNAs having a perfectly complementary or mismatched sequence to the let-7 miRNA. Cleavage products were resolved on 6% denaturing polyacrylamide gels. miRISCs purified by anti-Ago2 and anti-RCK/p54 antibodies showed efficient target let-7 cleavage ( Figure 5D, lanes 4 and 6). Ago2 antibodies captured more RISC activity on beads than RCK/p54 antibodies, as also observed in Figure 3A (lanes 6-9). Control experiments using IgG ( Figure 5D, lanes 1 and 2) did not show any miRISC activity purified by magnetic beads, supporting specific capture by Ago2 and RCK/p54 antibodies ( Figure 5D, lanes 4 and 6). miRISC did not cleave a mismatched substrate RNA for let-7 ( Figure 5D, lane 7). Despite the significant loss of P-body structures in cells treated with Lsm1 siRNA, the efficiency of let-7 target mRNA cleavage by miRISC purified by anti-RCK/p54 antibody was not significantly affected (compare Figure 3A, lane 9 with Figure 5D, lane 6). These results indicate that disrupting P-bodies by depleting Lsm1 did not significantly affect RCK/p54 association with miRISC.
###end p 30
###begin title 31
Depletion of RCK/p54 Does Not Affect RNAi Activity In Vivo
###end title 31
###begin p 32
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b052">52</xref>
To examine whether the P-body protein RCK/p54, also a component of RISC, is involved in siRNA-mediated gene silencing, the siRNA dose dependence of RNAi-mediated gene silencing was quantified in RCK/p54-depleted HeLa cells using a dual fluorescence reporter assay. Briefly, GFP and red fluorescent protein (RFP) were constitutively expressed in cells transfected with reporter plasmids for enhanced GFP (EGFP) and RFP, respectively. GFP expression was silenced by treating cells with a 21-nt siRNA targeting nt 238-258 of the EGFP mRNA. The fluorescence intensity ratio of target (GFP) to control (RFP) fluorophore was determined in the presence of siRNA duplexes and normalized to that observed in control-treated cells [ 52].
###end p 32
###begin p 33
###xml 239 247 239 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g006">Figure 6</xref>
###xml 447 455 447 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g006">Figure 6</xref>
###xml 499 507 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g006">Figure 6</xref>
###xml 738 746 738 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g006">Figure 6</xref>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b014">14</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b016">16</xref>
###xml 893 901 893 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g004">Figure 4</xref>
When HeLa cells were transfected with siRNA mismatched for CDK9 (control), the second transfection with GFP siRNA silenced GFP expression in a dose-dependent manner, i.e., GFP/RFP ratios decreased with increasing concentrations of siRNA ( Figure 6A, gray bars). Depleting RCK/p54 before quantifying GFP silencing resulted in moderate to no significant loss of RNAi activity, i.e., GFP/RFP again decreased with increasing concentrations of siRNA ( Figure 6A, green bars). Similarly, depleting Lsm1 ( Figure 6A, red bars) and the decapping enzyme, Dcp2 (unpublished data), before quantifying GFP silencing in HeLa cells did not significantly decrease RNAi activity. In contrast, prior depletion of Ago2 completely abolished RNAi activity ( Figure 6A, blue bars), as expected and consistent with previous reports [ 14- 16]. These results suggest that depleting RCK/p54, which disrupts P-bodies ( Figure 4), did not significantly affect siRNA-mediated RNAi in vivo.
###end p 33
###begin title 34
Depletion of RCK/p54 Does Not Affect RISC-Mediated mRNA Cleavage In Vitro
###end title 34
###begin p 35
###xml 413 421 412 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g006">Figure 6</xref>
###xml 427 428 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g006">6</xref>
###xml 699 707 697 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g006">Figure 6</xref>
###xml 889 890 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
To examine the role of RCK/p54 in RISC catalysis of mRNA processing, in vitro mRNA cleavage activity was assayed in extracts from RCK/p54-depleted HeLa cells. Cells were transfected with siRNAs against CDK9 mismatch (control), RCK/p54, Lsm1, or Ago2 and programmed 24 h later with GFP siRNA. Varying amounts of cytoplasmic extract (20-100 mug) were assayed in vitro for target mRNA cleavage activity. As shown in Figure 6B and 6C, cleavage activity increased with increasing protein concentration of extracts from both control and RCK/p54-depleted cells, reaching a robust cleavage (37%-41%) of target mRNA at the highest protein concentration (100 mug). In consistent with in vivo results shown in Figure 6A, Ago2 depletion abolished the target mRNA cleavage activities of RISC. These results show that RCK/p54 does not affect the slicer function of RISC in cleaving target mRNA in vitro .
###end p 35
###begin title 36
RCK/p54 Represses General and miRNA-Mediated Translation
###end title 36
###begin p 37
###xml 77 86 77 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g002">Figures 2</xref>
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">3</xref>
###xml 126 134 126 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b045">45</xref>
###xml 952 954 952 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 983 991 983 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 1033 1035 1033 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1138 1146 1138 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 1281 1283 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b045">45</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 442 447 <span type="species:ncbi:4932">yeast</span>
###xml 827 832 <span type="species:ncbi:9606">human</span>
###xml 1207 1212 <span type="species:ncbi:9606">human</span>
###xml 1247 1252 <span type="species:ncbi:4932">yeast</span>
Our results thus far demonstrate that RCK/p54 is a component of human RISC ( Figures 2 and 3) and enhances P-body formation ( Figure 1). Our data also show that siRNA-mediated RNAi may not require RCK/p54 and P-body cytoplasmic structures. Since we also identified that RCK/p54 associates with miRISC, we hypothesized that RCK/p54 might function in miRNA-mediated suppression of translation. A recent and intriguing report [ 45] identified a yeast homolog of RCK/p54, Dhh1p, which activates decapping and facilitates P-body formation, as a general translation repressor. We therefore reasoned that RCK/p54 might be a general translation repressor used by the miRNA machinery to dictate translation suppression of target mRNAs. To test this hypothesis, we first determined whether RCK/p54 was a general translation repressor in human cells. To this end, RCK/p54 expression was silenced in HeLa cells and general translational activity was analyzed by [ 35S]methionine incorporation ( Figure 7A). The translational rates measured by [ 35S]-labeling were significantly greater in RCK/p54-depleted cells than in control siRNA-treated cells ( Figure 7A), indicating that RCK/p54 was a translational repressor in human cells, consistent with results in yeast and reticulocyte extracts [ 45].
###end p 37
###begin p 38
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b056">56</xref>
###xml 462 480 462 480 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Renilla reniformis</named-content>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b056">56</xref>
###xml 656 657 656 657 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 961 977 961 977 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Photinus pyralis</named-content>
###xml 1178 1186 1178 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 1323 1325 1323 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b039">39</xref>
###xml 1327 1329 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b041">41</xref>
###xml 1388 1390 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b040">40</xref>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b041">41</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 462 480 <span type="species:ncbi:6136">Renilla reniformis</span>
###xml 961 977 <span type="species:ncbi:7054">Photinus pyralis</span>
Since RCK/p54 is a general translational repressor and a component of human RISC, we examined the effects of depleting RCK/p54 and disrupting P-bodies on siRNA- and miRNA-mediated gene silencing. To analyze siRNA- or miRNA-mediated gene-silencing events, we chose a well-established CXCR4 mRNA reporter system [ 56], in which siRNA- or miRNA-reporter constructs harbor 1 x perfectly matched or 4 x bulged CXCR4 siRNA target sites, respectively, in the 3' UTR of Renilla reniformis luciferase (RL) mRNA [ 56]. In this system, perfectly matched sequences are cleaved by siRISC and bulge-containing sequences are targets for translation suppression by miRISC . HeLa cells were co-transfected with siRNAs directed against P-body proteins (RCK/p54, GW182, Lsm1, and Ago2) and with siRNA or miRNA reporters in the absence or presence of 25 nM CXCR4 siRNA. At 24 h post-transfection, cells were harvested and RL activities were analyzed. RL signals were normalized to Photinus pyralis luciferase (FL) signals from cells co-transfected with pGL3 plasmid as control. Depletion of RCK/p54 released only miRNA-mediated gene suppression and had no effect on siRNA-mediated gene silencing ( Figure 7B). Depletion of GW182, an argonaute-interacting P-body protein, released gene suppression by miRNA, consistent with previous findings [ 39- 41], and moderately released siRNA-mediated gene silencing [ 40, 41]. Ago2 depletion significantly released siRNA-mediated gene silencing and moderately released miRNA-mediated gene suppression. Knockdown of Lsm1 had no significant effect on either miRNA- or siRNA-mediated gene silencing. Taken together, these results show that RCK/p54 depletion releases miRNA-mediated translation suppression of reporter genes, but does not affect siRNA-mediated RNAi.
###end p 38
###begin p 39
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b013">13</xref>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 507 515 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 593 594 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b053">53</xref>
###xml 833 854 833 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 984 987 984 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b013">13</xref>
###xml 1165 1173 1165 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 1275 1276 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1376 1379 1376 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 1432 1441 1432 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="sg003">Figure S3</xref>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 631 636 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We next hypothesized that the expression of a specific cellular protein, known to be controlled by miRNAs, might be up-regulated in RCK/p54-depleted cells. Such a protein, human RAS, has been elegantly shown by Slack and colleagues [ 13] to be regulated by the let-7 miRNA family. To test our hypothesis, we analyzed RAS protein levels in HeLa cells under two conditions: either let-7 function was inhibited by 2'- O-Me oligonucleotides complementary to the let-7 sequence or RCK/p54 was depleted by RNAi ( Figure 7C). For control experiments, we treated cells with a CDK9 mm siRNA and a 2' - O-Me oligonucleotide complementary to HIV-1 TAR RNA sequence [ 53]. Total cellular protein extracts from equal numbers of cells were prepared and analyzed by immunoblot using monoclonal anti-RAS antibodies directly conjugated with HRP (see Materials and Methods). Actin protein levels were measured as a control using HRP-conjugated anti-actin primary antibody. When cells were treated with let-7 inhibitor, RAS protein levels increased, consistent with previous findings [ 13]. Strikingly, RAS protein expression in RCK/p54-depleted cells also showed a robust increase ( Figure 7C) while RAS levels were not significantly affected when cells were treated with control siRNA or 2'- O-Me oligonucleotides. RAS mRNA levels did not differ drastically in HeLa cells after treatment with let-7 inhibitor, RCK/p54 silencing, or mock treatment ( Figure S3).
###end p 39
###begin p 40
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7</italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b053">53</xref>
###xml 377 380 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 541 542 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 562 570 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b013">13</xref>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
###xml 838 839 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1103 1111 1103 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 304 309 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To further probe our findings of endogenous RAS regulation by RCK/p54, we co-transfected HeLa cells with RAS 3' UTR reporter constructs and let-7 2' - O-Me inhibitor or siRNA against RCK/p54. For control experiments, we treated cells with a CDK9 mm siRNA and a 2' - O-Me oligonucleotide complementary to HIV-1 TAR RNA sequence [ 53]. Cells transfected with a control siRNA and let-7 inhibitor induced more firefly luciferase expression when reporter plasmids contained 3' UTR sequences for NRAS and KRAS than for the control siRNA and a 2'- O-Me oligo control ( Figure 7D), consistent with a recent report [ 13]. Depleting RCK/p54 by siRNA and adding a control 2'- O-Me oligo also released translation repression from both NRAS and KRAS vectors. Interestingly, combining these two approaches to release translation suppression, let-7 2'- O-Me oligo and RCK/p54 depletion, did not show additive effects to induce NRAS and KRAs expression. In all of these experiments, slightly greater firefly luciferase expression was induced from pGL3-NRAS than from KRAS vectors. These results, combined with those of Figure 7A-C, strongly suggest that RCK/p54 is a general translation repressor that associates with RISC to regulate miRNA-mediated translation repression.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 455 458 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 586 591 <span type="species:ncbi:9606">human</span>
We have identified RCK/p54 as a protein that interacts with Ago2 in affinity-purified RISC assemblies to facilitate formation of cytoplasmic P-bodies and that acts as a general translational repressor in human cells. We have shown that depletion of RCK/p54 disrupts P-bodies and disperses the cytoplasmic localization of Ago2. Furthermore, depletion of RCK/p54 did not significantly affect the RNAi function of RISC, although general, miRNA-mediated, and let-7-mediated translational repression were released. Together, our results provide significant insights into miRNA mechanisms in human cells (see below).
###end p 42
###begin p 43
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b028">28</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b031">31</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b029">29</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b028">28</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b031">31</xref>
###xml 524 546 524 546 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b057">57</xref>
###xml 995 1003 995 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 1357 1366 1357 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g002">Figures 2</xref>
###xml 1371 1372 1371 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">3</xref>
###xml 1704 1712 1680 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 2000 2008 1974 1982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 2014 2015 1988 1989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">1</xref>
###xml 355 360 <span type="species:ncbi:9606">human</span>
###xml 524 546 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Several recent reports show that RISC co-localizes with P-bodies, suggesting that they could be the site where RISC degrades target mRNA or represses mRNA translation [ 28- 31]. Isolation of miRNAs on polysomes also links the suppression of protein synthesis with arrest of translation initiation or elongation [ 29]. These studies also demonstrated that human Ago1 and Ago2 co-localize in P-bodies with other cellular proteins, such as Dcp1a, Dcp2, GW182, Lsm1, and Xrn1 [ 28- 31]. A homolog of the P-body protein GW182 in Caenorhabditis elegans is the developmental timing regulator AIN-1, which also interacts with miRISCs and may target argonaute proteins to P-bodies [ 57]. To dissect and understand the relationship between RNAi function and P-bodies, we affinity-purified RISC using Myc-Ago2 and expression vectors of the YFP-tagged P-body proteins, Lsm1, RCK/p54, Dcp2, and eIF4E. Ago2 interacted with these various P-body components in ways that were RNA-dependent or RNA-independent ( Figure 1A). Ago1 and RCK/p54 immunoprecipitated with Ago2 after RNase A treatment of HeLa cell extracts, suggesting that these proteins directly interact with Ago2. Interestingly, RCK/p54, Ago1, and Ago2 were also identified as a component of active RISC programmed with siRNA or miRNA and purified by biotin affinity to streptavidin-conjugated magnetic beads ( Figures 2 and 3). We examined the P-body localization of Ago2 with Lsm1 and RCK/p54 by co-expressing YFP-tagged Lsm1 and RCK/p54 with CFP-Ago2. Interestingly, overexpressing YFP-RCK/p54 in HeLa cells increased the number of P-bodies (from approximately 8 to approximately 20 foci/cell). The number of P-bodies containing CFP-Ago2 also increased ( Figure 1B). These results suggested a functional relationship between RCK/p54-Ago interactions and their localization to P-bodies. To visualize protein-protein interactions in vivo, we used FRET as a probe. In cells expressing YFP-RCK/p54 and CFP-Ago2, the FRET efficiency was 21.07% +/- 2.52% ( Figure 1C and 1D). We also observed an efficient FRET between YFP-Ago1 and CFP-Ago2; however, FRET between RCK/p54 and Ago1 was moderate (6.41% +/- 1.96%). Since FRET is quite sensitive to the orientation of the donor: acceptor pair, it is possible that CFP and YFP in Ago1 and RCK/p54 are not suitably positioned for efficient energy transfer. Nonetheless, the FRET efficiency between Ago1 and RCK/p54 was significantly above the 0.9% background. Taken together, these results demonstrate that Ago1, Ago2, and RCK/p54 directly interact in vivo.
###end p 43
###begin p 44
###xml 320 323 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 334 342 334 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">Figure 5</xref>
###xml 457 466 457 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g003">Figures 3</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g005">5</xref>
Where in the cell does this physical interaction between RISC and RCK/p54 take place and does it require P-body structures? To address these questions, we disrupted P-bodies in cells by depleting Lsm1 and immunopurified endogenous miRISC, and analyzed its ability to cleave a target mRNA with perfect complementarity to let-7 miRNA ( Figure 5). We observed no significant difference in miRISC activities purified from Lsm1-depleted and non-depleted cells ( Figures 3 and 5) even though the P-body structures were disrupted and the total number of P-bodies per cell had significantly decreased. These results show that RCK/p54 association with RISC does not require P-bodies and suggest that localization of RISC to P-bodies is the outcome of translation repression by miRISC.
###end p 44
###begin p 45
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g006">Figure 6</xref>
###xml 423 431 423 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g004">Figure 4</xref>
###xml 611 621 611 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b039">39</xref>
###xml 792 793 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 904 914 904 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b039">39</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b040">40</xref>
###xml 1074 1076 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b041">41</xref>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b041">41</xref>
###xml 1228 1233 <span type="species:ncbi:9606">human</span>
Having established the physical interactions of RCK/p54 with RISC, we questioned the functional relevance of these interactions in the RNAi pathway and how they could facilitate RISC activity. To that end, we depleted RCK/p54 in HeLa cells and analyzed RNAi activities in vivo and in vitro ( Figure 6). Depletion of RCK/p54 clearly disrupted the P-body structures and dispersed Ago2 localization throughout the cytoplasm ( Figure 4). Surprisingly, depleting RCK/p54 did not significantly affect siRNA-mediated gene silencing. Similar results showing the lack of P-body involvement in RNAi have been reported in Drosophila [ 39]. In that system, depletion of the P-body proteins, GW182 or Dcp1:Dcp2 decapping complex, showed that these proteins were required for miRNA-mediated gene silencing , but RNAi efficiency was not affected, suggesting that these two gene-silencing mechanisms were independent in Drosophila [ 39]. In addition, two recent studies reported that mammalian GW182 interacts with Ago2 and plays a role in miRNA function [ 40] and in siRNA-mediated RNAi [ 41]. Interestingly, depleting GW182 disrupted cytoplasmic foci and interfered with RNAi activity [ 41]. It is possible that GW182 is directly involved in human RISC function and does not spatially require P-bodies for its function. As an alternative approach to disrupting P-bodies, we treated HeLa cells with the translation inhibitor, cycloheximide, which did not significantly affect RNAi activities in vivo and in vitro (unpublished data). Taken together, these results strongly suggest that functional siRISC is assembled before locating to P-bodies, and P-bodies are not prerequisite sites for siRNA-mediated gene silencing.
###end p 45
###begin p 46
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b056">56</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b056">56</xref>
###xml 559 567 559 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b039">39</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b041">41</xref>
To determine the role of RCK/p54 in miRNA-mediated translation repression, we used a CXCR4 reporter system [ 56], in which siRNA- or miRNA-reporter constructs harbor 1 x perfectly matched or 4 x bulged CXCR4 siRNA target sites, respectively in the 3' UTR of RL mRNA [ 56]. In this system, perfectly matched sequences are cleaved via siRISC and bulge-containing sequences are targets for translation suppression by miRISC. We observed that depletion of RCK/p54 released only miRNA-mediated gene suppression and had no effect on siRNA-mediated gene silencing ( Figure 7B). Depletion of GW182, an argonaute-interacting P-body protein, released gene suppression by miRNA and moderately affected reporter constructs containing perfectly matched target sequences, consistent with previous findings [ 39- 41]. Ago2 depletion significantly released siRNA-mediated gene silencing and moderately affected reporters containing 4 x bulged sequences. Knockdown of Lsm1 had no significant effect on either miRNA- or siRNA-mediated gene silencing. These results show that RCK/p54 depletion releases miRNA-mediated translation suppression of reporter genes and that this function of RCK/p54 was not significantly affected when P-bodies were disrupted by depleting Lsm1.
###end p 46
###begin p 47
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 253 256 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 304 307 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b013">13</xref>
###xml 373 376 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b013">13</xref>
###xml 608 616 608 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g007">Figure 7</xref>
###xml 654 657 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 247 252 <span type="species:ncbi:9606">human</span>
To test our hypothesis that RCK/p54 mediates the translational repression of endogenous miRNA targets in P-bodies, we examined RAS protein levels in RCK/p54-depleted cells. We chose RAS because it is an endogenous target of let-7 , and 3' UTRs of human RAS genes contain multiple complementary sites for let-7 to bind and regulate RAS expression levels [ 13]. Furthermore, let-7 inhibitors are known to enhance RAS protein expression in HeLa cells [ 13]. Depleting RCK/p54 in HeLa cells up-regulated RAS protein, and this increase in RAS levels was higher than that in general translation of control actin ( Figure 7C), suggesting that multiple sites of let-7 miRISC binding to target 3' UTR dictate the potency and specificity of translation suppression.
###end p 47
###begin p 48
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b042">42</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b033">33</xref>
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b043">43</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b044">44</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b045">45</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b045">45</xref>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b045">45</xref>
###xml 1083 1085 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b029">29</xref>
###xml 1087 1089 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b058">58</xref>
###xml 1196 1198 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b059">59</xref>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b060">60</xref>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b061">61</xref>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 30 35 <span type="species:ncbi:4932">yeast</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 261 268 <span type="species:ncbi:8355">Xenopus</span>
###xml 421 426 <span type="species:ncbi:4932">yeast</span>
RCK/p54, the human homolog of yeast Dhh1p, is a member of the ATP-dependent DEAD box helicase family and was originally identified as a proto-oncogene [ 42]. In human cells, RCK/p54 interacts in P-bodies with the translation initiation factor, eIF4E [ 33]. The Xenopus homolog of RCK/p54, Xp54, which interacts with eIF4E and forms RNA-dependent oligomers, represses the translation of mRNA in oocytes and eggs [ 43]. In yeast, Dhh1p interacts with the decapping and deadenylase complex and functions in translational repression [ 44]. Dhh1p has recently been shown to stimulate translational repression by inhibiting production of the pre-initiation complex [ 45]. Dhh1p and RCK/p54 also inhibit the mRNA translation driven by internal ribosomal entry sites in vitro, suggesting that this protein is a general translational repressor that may not require a cap structure for its function [ 45]. However, the in vivo function of Dhh1p required translational initiation [ 45]. Translation repression by miRISC and P-body localization require the 5'-cap structure in the target mRNA [ 29, 58], which provides a unique and elegant control mechanism for translation and its regulation (reviewed in [ 59, 60]). Recently, Petersen et al. reported an intriguing study showing that miRNA represses translation after initiation by a ribosome drop-off mechanism [ 61]. Therefore, it is possible that RCK/p54 interacts with miRISC and blocks translation elongation by binding to its multiple target sites with high affinity and creates a barrier for elongating ribosomes (see below).
###end p 48
###begin p 49
###xml 305 313 305 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g008">Figure 8</xref>
###xml 601 609 601 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g008">Figure 8</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b056">56</xref>
###xml 1509 1511 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b061">61</xref>
We therefore propose that the function of RISC assemblies in cells can be described by a model with two independent pathways, depending on whether RNAi is programmed by the guide strand of siRNA or miRNA. In the first pathway, the RISC recognizes a perfectly matched target mRNA and functions as siRISC ( Figure 8) by cleaving its target mRNA. This target mRNA cleavage activity and rapid turnover of siRISC induce the subsequent target mRNA degradation by exonucleases and does not require P-bodies. In the second pathway, the RISC recognizes the imperfectly matched target and functions as miRISC ( Figure 8). Multiple copies of miRISC containing RCK/p54 could initiate an oligomerization event that sequesters the whole RNP and transports it to the P-bodies. This sequestration could also explain the cooperative effects of RISC function that enhance translation repression [ 56]. Once in P-bodies, translationally repressed mRNA could stay in oligomeric structures for storage or it could form a complex with decapping enzymes and cap binding proteins that would lead to the mRNA decay pathway. In other words, the miRNA in RISC could provide the sequence specificity and RCK/p54 could be the effector molecule that shuttles the target mRNA toward the fate of storage or processing in P-bodies. Since P-bodies are not a prerequisite for RCK/p54 to assemble into RISC or to function, it is possible that miRISC blocks protein synthesis by enhancing the ribosome drop-off during elongation of translation [ 61]. We propose that miRISC localization to P-bodies is the outcome of translation repression and not a prerequisite for miRISC function. Stored mRNA in P-bodies could reenter the active translation or mRNA decay pathway depending upon cellular conditions or stimuli that are presently unknown. How long mRNA translation can be repressed in the cytoplasm and which factors trigger mRNA transport to P-bodies are exciting areas for future research.
###end p 49
###begin p 50
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b009">9</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b012">12</xref>
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b013">13</xref>
###xml 513 520 513 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 534 545 534 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila,</italic>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b043">43</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b062">62</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b063">63</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b064">64</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b065">65</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b066">66</xref>
###xml 882 890 882 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040210-g001">Figure 1</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b033">33</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b045">45</xref>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 513 520 <span type="species:ncbi:8355">Xenopus</span>
###xml 703 708 <span type="species:ncbi:9606">human</span>
###xml 744 761 <span type="species:ncbi:11103">hepatitis C virus</span>
Our results on the interactions between RCK/p54 and the RNAi machinery suggest an intriguing role for miRNA function in development and carcinogenesis. However, most targets of miRNA have not yet been identified. A growing body of evidence suggests that miRNAs are important in human disease, including cancers [ 9- 12]. For example, relatively low levels of let-7 miRNA up-regulate RAS protein in lung cancer cells, demonstrating a possible role of miRNA in tumorigenesis [ 13]. Two homologs of RCK/p54, Xp54 in Xenopus and Me31b in Drosophila, control the translation of maternal mRNA in oocytes [ 43, 62, 63]. Altered regulation of RCK/p54 expression levels has been implicated in the development of human colorectal tumors [ 64, 65] and in hepatitis C virus-related chronic hepatitis [ 66]. Overexpression of RCK/p54 and Dhh1p increases the number of Ago2-containing P-bodies ( Figure 1B; [ 33, 45]), suggesting that RCK/p54 is a critical factor in controlling cellular translation. Our results have identified RCK/p54 as an essential component of miRISC-mediated translation repression and provide a functional link between miRISC and P-bodies. In the context of spatially and temporally restricted miRNA expression, this system allows for exquisite regulation of protein expression by target mRNA. Therefore, perturbations of either miRNA or RCK/p54 expression levels can have deleterious consequences for the cell. What determines the balance between active translation and repression of mRNAs targeted by miRISC, and how cells control the specificity of this repression are key directions for future investigation.
###end p 50
###begin title 51
Materials and Methods
###end title 51
###begin title 52
Expression vectors.
###end title 52
###begin p 53
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ago</italic>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ago</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
Ago1 and Ago2 expression vectors with N-terminal YFP- or CFP-epitope tags were generated by PCR amplification of Ago1 and Ago2 coding sequences from pMyc-Ago1 and pMyc-Ago2 followed by cloning into the XbaI and EcoRI sites of pEYFP-C1 and pECFP-C1 (BD Biosciences, Palo Alto, California, United States). Expression vectors were kindly provided by four laboratories: pMyc-Ago1/2 (Dr. G. Hannon); pFlag-Ago1/Ago2 (Dr. T. Tuschl); pGL3-control, pGL3-KRAS, and pGL3-NRAS (Dr. F. Slack); and pRL-TK-1P and pRL-TK-4B (Dr. P. Sharp).
###end p 53
###begin p 54
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BglII</italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SalI</italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b067">67</xref>
Vectors for expressing YFP-tagged Lsm1, RCK/p54, eIF4E, and Dcp2 were generated through PCR amplification of their coding sequences from 293T cDNA followed by cloning into the BglII and SalI sites of pEYFP-C1 [ 67].
###end p 54
###begin title 55
siRNAs.
###end title 55
###begin p 56
###xml 20 25 <span type="species:ncbi:9606">human</span>
siRNAs against GFP, human Ago2, RCK/p54, Lsm1, and CDK9 mismatch were synthesized by Dharmacon (Dharmacon, Lafayette, Colorado, United States) and 2'-OH deprotected according to the manufacturer's protocols. The sequences of siRNAs (passenger strand) for our experiments were:
###end p 56
###begin p 57
GFP: 5'- GCAGCACGACUUCUU CAAGdTdT-3'; hAgo2: 5'- GCACGGAAGUCCAUCUGAAdTdT-3'
###end p 57
###begin p 58
RCK/p54: 5'- GCAGAAACCCUAU GAGAUUUU-3'; CDK9mm: 5'- CCAAAGCUCU CCCCUAUAAdTdT-3'; Lsm1: 5'-GU GACAUCCU GCCACCUCACUU-3'
###end p 58
###begin title 59
Cell culture and transfection.
###end title 59
###begin p 60
###xml 131 132 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 86 92 <span type="species:ncbi:9913">bovine</span>
HeLa cells were cultured in Dulbecco's minimal essential medium (DMEM) with 10% fetal bovine serum (FBS) at 37 degreesC with 5% CO 2. Cells were transfected using Lipofectamine (Invitrogen, Carlsbad, California, United States) according to the manufacturer's protocol.
###end p 60
###begin title 61
Immunoprecipitation and immunoblotting.
###end title 61
###begin p 62
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 612 618 <span type="species:ncbi:9986">rabbit</span>
###xml 957 962 <span type="species:ncbi:10090">mouse</span>
###xml 1102 1108 <span type="species:ncbi:9986">rabbit</span>
###xml 1231 1238 <span type="species:ncbi:9031">chicken</span>
TCEs were prepared by incubating cells in lysis buffer (20 mM HEPES [pH 7.9], 10 mM NaCl, 1 mM MgCl 2, 0.2 mM EDTA, 0.35% [v/v] Triton X-100, 1/100 [v/v] dilution in protease inhibitor cocktail) and centrifuging at 14,000 rpm for 10 min at 4 degreesC. Protein concentration was determined by Dc protein assay (Bio-Rad, Hercules, California, United States). To examine the RNA dependence of protein-protein interactions, TCEs (250 mug) were treated before immunoprecipitation with 0.2 mug/ul of RNase A for 20 min at room temperature. Myc-tagged proteins were precipitated by incubating overnight with polyclonal rabbit anti-Myc antibodies directly conjugated to agarose beads (Santa Cruz Biotech, California, United States). Samples were washed four times in lysis buffer and eluted by boiling for 5 min at 100 degreesC in SDS-PAGE sample loading buffer, separated by SDS-PAGE, and analyzed by immunoblot. For immunoblotting, antibodies included monoclonal mouse anti-GFP (BD Biosciences), anti-eIF4E and anti-Myc (Santa Cruz Biotech), anti-Flag (Sigma, St. Louis, Missouri, United States); polyclonal rabbit anti-Myc (Santa Cruz Biotech), anti-DDX6 (rck/p54; Bethyl Laboratories, Montgomery, Texas, United States); and polyclonal chicken anti-Lsm1 (GenWay Biotech Incorporated, San Diego, California, United States).
###end p 62
###begin p 63
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 154 157 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 629 632 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 268 274 <span type="species:ncbi:9986">rabbit</span>
To assess the ability of endogenous immunopurified miRISC to cleave target mRNA with perfect complementarity to let-7 miRNA, in vitro cleavage assays for let-7 miRISC were conducted. Aliquots (30 mul) of magnetic protein A beads (Dynal, Norway) were preincubated with rabbit IgG, anti-Ago2, or anti-RCK/p54 antibodies according to the manufacturer's protocol and incubated overnight at 4 degreesC with 500 mug HeLa cytoplasmic extracts. Beads were then washed three times with Na-phosphate buffer [pH 8.0], one time with lysis buffer, and resuspended in 30 mul of lysis buffer. Aliquots (10 mul) of these beads were used in each let-7 miRISC cleavage assay.
###end p 63
###begin title 64
Live cell imaging, FRET, and immunofluorescence.
###end title 64
###begin p 65
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b048">48</xref>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b049">49</xref>
###xml 1130 1132 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b068">68</xref>
###xml 1666 1672 <span type="species:ncbi:9986">rabbit</span>
###xml 1678 1683 <span type="species:ncbi:10090">mouse</span>
###xml 1693 1700 <span type="species:ncbi:9031">chicken</span>
HeLa cells were cultured in 35 mm dishes with glass coverslip bottoms (MatTek Corporation, Ashland, Massachusetts, United States). Expression vectors for CFP- or YFP-tagged proteins were transfected into cells using Lipofectamine as described above. 24 h later, the live cells were monitored for CFP and YFP signals of the transiently expressed proteins. The signals were detected by a Leica (Wetzlar, Germany) confocal imaging spectrophotometer system (TCS-SP2) attached to a Leica DMIRE inverted fluorescence microscope equipped with an argon laser, two HeNe lasers, an acousto-optic tunable filter (AOTF) to attenuate individual visible laser lines, and a tunable acousto-optical beam splitter (AOBS). A 63 x 1.32 NA oil-immersion objective was employed. For FRET studies, HeLa cells co-expressing CFP- and YFP-tagged proteins were fixed with 4% paraformaldehyde in PBS at room temperature for 20 min and washed three times with PBS. After the final wash, cells were visualized with a Leica confocal imaging system as described above. FRET experiments were performed by an acceptor photobleaching method as described [ 48, 49, 68]. FRET efficiencies were measured and images were analyzed using Leica confocal software. For immunofluorescence studies, cells transfected with Myc-Ago2 were fixed with 4% paraformaldehyde in PBS at room temperature for 20 min and permeabilized with 0.25% (v/v) Triton X-100 for 5 min. Samples were washed three times with PBST (0.1% [v/v] Triton X-100 in PBS) and blocked for 30 min in PBST containing 2% (w/v) BSA. Primary and secondary antibodies were diluted in blocking solution during incubation. Secondary antibodies against rabbit IgG, mouse IgG, and chicken IgY were directly conjugated to Alexa Fluor dyes (Molecular Probes, Eugene, Oregon, United States). After the final wash, samples were counterstained with Hoechst 33258 to visualize nuclei with a Leica confocal imaging system as described above.
###end p 65
###begin title 66
In vitro cleavage assay for siRISC and miRISC.
###end title 66
###begin p 67
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b053">53</xref>
HeLa cells sequentially transfected with siRNAs against P-body components and EGFP were harvested 24 h after the second transfection. Cytoplasmic extracts of HeLa cells were prepared as described above and the protein concentration was determined by Dc protein assay (Bio-Rad). Target mRNAs were prepared and in vitro cleavage by GFP-siRISC and let-7-miRISC was assayed as described [ 53].
###end p 67
###begin title 68
Dual fluorescence assay.
###end title 68
###begin p 69
A dual fluorescence assay was used to quantify the RNAi activity of siRNAs against GFP. To quantify RNAi effects, cell lysates were prepared from siRNA-treated cells 24 h post-transfection. Total cell lysate (150 mug in 200 mul of reporter lysis buffer) was measured using a Safire plate reader (TECAN). GFP fluorescence was detected in cell lysates by exciting at 488 nm and recording emissions from 504-514 nm. The spectrum peak at 509 nm represents the fluorescence intensity of GFP. RFP fluorescence was detected in the same cell lysates by exciting at 558 nm and recording emissions from 578-588 nm. The spectrum peak at 583 nm represents the fluorescence intensity of RFP. The fluorescence intensity ratio of target (GFP) to control (RFP) fluorophores was determined in the presence of siRNA duplexes and normalized to the emissions measured in mock-treated cells. Normalized ratios < 1.0 indicated specific RNA interference.
###end p 69
###begin title 70
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
Incorporation of [ 35S]methionine.
###end title 70
###begin p 71
###xml 312 314 311 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
HeLa cells cultured in 6-well plates were transfected with siRNAs against RCK/p54 or CDK9 mismatch as a scramble control. 24 h post-transfection, cells were incubated for 1 h in culture medium lacking methionine and cysteine, and metabolically labeled by incubating in culture medium containing 100 muCi/ml Tran 35S-label (MP Biomedicals, Irvine, California, United States). At 0, 15, 30, 60, and 120 min after metabolic labeling, cells were washed twice and harvested in 300 mul M-PER buffer (Pierce, Rockford, Illinois, United States) with protease inhibitors (Sigma). For each experiment, two extra sets of siRNA-treated cells were trypsinized and counted for total cell numbers. Cell lysates (50 mul) were incubated with 10 mul of 100% TCA on ice for 30 min, and the protein precipitate was collected on GF/C filter paper (Whatman, Clifton, New Jersey, United States), washed with 5 ml of 95% ethanol and counted in scintillation fluid.
###end p 71
###begin title 72
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
Dual luciferase assay for let-7 miRNA-mediated gene silencing.
###end title 72
###begin p 73
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 208 210 207 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pp</italic>
###xml 290 295 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7</italic>
###xml 300 301 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 451 453 450 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rr</italic>
###xml 739 741 737 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pp</italic>
###xml 747 749 745 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rr</italic>
###xml 832 837 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7</italic>
###xml 106 111 <span type="species:ncbi:9606">human</span>
A dual luciferase assay was used to quantify the effects of let-7- and RCK/p54-mediated gene silencing on human NRAS or KRAS 3' UTR. HeLa cells cultured in 6-well plates were co-transfected with 0.8 mug/well Pp-luc-expressing vectors (pGL3-control, pGL3-NRAS, or pGL3-KRAS) and with 100 nM let-7-2'- O-Me inhibitor or 50 nM siRNA against RCK/p54. In all experiments, transfection efficiencies were normalized to those of cells co-transfected with the Rr-luc-expressing vector (pRL-TK; 0.1 mug/well). TCEs were prepared 48 h post-transfection and dual luciferase assays (Promega, Madison, Wisconsin, United States) were performed according to the manufacturer's protocol and quantified with a Victor2 multilabel counter (Perkin Elmer). The Pp-luc/ Rr-luc signals were normalized to those from pGL3-control-transfected cells, showing let-7-regulated gene silencing of RAS 3' UTR.
###end p 73
###begin title 74
siRNA or miRNA luciferase reporter assays.
###end title 74
###begin p 75
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b056">56</xref>
To analyze siRNA- or miRNA-mediated gene-silencing events, we chose the CXCR4 mRNA reporter system, in which siRNA- or miRNA-reporter constructs harbor 1 x perfectly matched or 4 x bulged CXCR4 siRNA target sites, respectively, in the 3' UTR of RL mRNA [ 56]. HeLa cells transfected with siRNAs directed against P-body proteins (RCK/p54, GW182, Lsm1, Ago2) were co-transfected again with siRNA or miRNA reporters in the absence or presence of 25 nM CXCR4 siRNA. At 24 h post-transfection, cells were harvested and RL activities were analyzed. RL signals were normalized to the FL signals from cells co-transfected with pGL3 plasmid as control.
###end p 75
###begin title 76
Supporting Information
###end title 76
###begin title 77
Subcellular Localization of Endogenous Ago2 in HeLa Cells
###end title 77
###begin p 78
HeLa cells were analyzed by immunofluorescence using antibodies against endogenous Ago2 (A) and Lsm1 (B), and stained with Hoechest 33258 to visualize the nucleus. The images were digitally merged to indicate co-localization of Ago2 and Lsm1 (C). Arrows point to P-bodies.
###end p 78
###begin p 79
(4.2 MB TIF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin title 81
Specific Depletion of RCK/p54 in HeLa Cells by RNAi
###end title 81
###begin p 82
(A) Specific knockdown of RCK/p54 in HeLa cells. HeLa cells were transfected with 50 nM siRNA against RCK/p54, harvested at 24, 48, and 72 h post-transfection, and TCEs were prepared. Analysis by immunoblot shows the specific knockdown of RCK/p54 protein without changing the protein levels of Lsm1 or Ago2.
###end p 82
###begin p 83
(B) Specific depletion of RCK/p54 mRNA after siRNA treatment. Total RNA samples (3 mug) from HeLa cells transfected with siRNA against RCK/p54 were reverse-transcribed and analyzed by quantitative PCR to quantify mRNA levels. RCK/p54 mRNA levels were normalized to GAPDH mRNA and are presented relative to mock treatment. Data are from two representative, independent experiments.
###end p 83
###begin p 84
(1.7 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin title 86
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Let</italic>
Let-7 Inhibition Does Not Affect RAS mRNA Levels
###end title 86
###begin p 87
###xml 69 72 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 79 81 78 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
Total RNA samples (3 mug) from HeLa cells transfected with 100 nM of let-7 2'- O-Me oligonucleotides or 50 nM siRNA against RCK/p54 were reverse-transcribed and analyzed by quantitative PCR to quantify mRNA levels. RAS mRNA levels were normalized to GAPDH mRNA and are presented relative to mock treatment. Data are from two representative, independent experiments.
###end p 87
###begin p 88
(1.5 MB TIF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin title 90
Accession Numbers
###end title 90
###begin p 91
The RefSeq ( ) accession numbers for the proteins discussed in this paper are Ago1 (NM_012199), Ago2 (NM_012154), Dcp2 (NM_152624), eIF4E (NM_001968), Lsm1 (NM_014462), and RCK/p54 (NM_004397).
###end p 91
###begin p 92
We thank Drs. Gregory Hannon, Tom Tuschl, Frank Slack, and Phillip Sharp for kindly providing reagents. We thank Craig Mello and members of the Rana lab for helpful discussions.
###end p 92
###begin p 93
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 93
###begin title 94
References
###end title 94
###begin article-title 95
MicroRNA function in animal development
###end article-title 95
###begin article-title 96
The functions of animal microRNAs
###end article-title 96
###begin article-title 97
MicroRNAs: Genomics, biogenesis, mechanism, and function
###end article-title 97
###begin article-title 98
RNAi: The nuts and bolts of the RISC machine
###end article-title 98
###begin article-title 99
###xml 67 89 67 89 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 67 89 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
###end article-title 99
###begin article-title 100
Ribo-gnome: The big world of small RNAs
###end article-title 100
###begin article-title 101
RNA silencing in plants
###end article-title 101
###begin article-title 102
###xml 15 26 <span type="species:ncbi:3702">Arabidopsis</span>
Small RNAs and Arabidopsis. A fast-forward look
###end article-title 102
###begin article-title 103
###xml 38 43 <span type="species:ncbi:9606">human</span>
A microRNA polycistron as a potential human oncogene
###end article-title 103
###begin article-title 104
###xml 38 43 <span type="species:ncbi:9606">human</span>
MicroRNA expression profiles classify human cancers
###end article-title 104
###begin article-title 105
A pancreatic islet-specific microRNA regulates insulin secretion
###end article-title 105
###begin article-title 106
###xml 4 14 4 14 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">C. elegans</named-content>
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7</italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7</italic>
###xml 4 14 <span type="species:ncbi:6239">C. elegans</span>
The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3' UTR
###end article-title 106
###begin article-title 107
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7</italic>
RAS is regulated by the let-7 microRNA family
###end article-title 107
###begin article-title 108
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
###end article-title 108
###begin article-title 109
Argonaute2 is the catalytic engine of mammalian RNAi
###end article-title 109
###begin article-title 110
Crystal structure of Argonaute and its implications for RISC slicer activity
###end article-title 110
###begin article-title 111
###xml 61 84 61 84 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Drosophila melanogaster</named-content>
###xml 61 84 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate
###end article-title 111
###begin article-title 112
A microRNA in a multiple-turnover RNAi enzyme complex
###end article-title 112
###begin article-title 113
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
###end article-title 113
###begin article-title 114
Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein
###end article-title 114
###begin article-title 115
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing
###end article-title 115
###begin article-title 116
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing
###end article-title 116
###begin article-title 117
Argonaute 2, a link between genetic and biochemical analyses of RNAi
###end article-title 117
###begin article-title 118
Fragile X-related protein and VIG associate with the RNA interference machinery
###end article-title 118
###begin article-title 119
MicroRNAs: Small RNAs with a big role in gene regulation
###end article-title 119
###begin article-title 120
MicroRNA-directed cleavage of HOXB8 mRNA
###end article-title 120
###begin article-title 121
MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms
###end article-title 121
###begin article-title 122
Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies
###end article-title 122
###begin article-title 123
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7</italic>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Inhibition of translational initiation by let-7 microRNA in human cells
###end article-title 123
###begin article-title 124
RNAi and the P-body connection
###end article-title 124
###begin article-title 125
MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies
###end article-title 125
###begin article-title 126
Eukaryotic mRNA decapping
###end article-title 126
###begin article-title 127
A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies
###end article-title 127
###begin article-title 128
A role for the eIF4E-binding protein 4E-T in P-body formation and mRNA decay
###end article-title 128
###begin article-title 129
A nuclear translation-like factor eIF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay
###end article-title 129
###begin article-title 130
Identification of novel argonaute-associated proteins
###end article-title 130
###begin article-title 131
A conserved role of a DEAD box helicase in mRNA masking
###end article-title 131
###begin article-title 132
###xml 44 49 <span type="species:ncbi:9606">human</span>
Cytoplasmic foci are sites of mRNA decay in human cells
###end article-title 132
###begin article-title 133
A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing
###end article-title 133
###begin article-title 134
A role for the P-body component GW182 in microRNA function
###end article-title 134
###begin article-title 135
Disruption of GW bodies impairs mammalian RNA interference
###end article-title 135
###begin article-title 136
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
The RCK/p54 candidate proto-oncogene product is a 54-kilodalton DEAD box protein differentially expressed in human and mouse tissues
###end article-title 136
###begin article-title 137
The active form of Xp54 RNA helicase in translational repression is an RNA-mediated oligomer
###end article-title 137
###begin article-title 138
The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes
###end article-title 138
###begin article-title 139
General translational repression by activators of mRNA decapping
###end article-title 139
###begin article-title 140
FRET tells us about proximities, distances, orientations, and dynamic properties
###end article-title 140
###begin article-title 141
Forster distances between green fluorescent protein pairs
###end article-title 141
###begin article-title 142
Imaging the intracellular trafficking and state of the AB5 quaternary structure of cholera toxin
###end article-title 142
###begin article-title 143
Dissecting RNA-interference pathway with small molecules
###end article-title 143
###begin article-title 144
Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein
###end article-title 144
###begin article-title 145
###xml 8 13 <span type="species:ncbi:9606">human</span>
RNAi in human cells: Basic structural and functional features of small interfering RNA
###end article-title 145
###begin article-title 146
siRNA function in RNAi: A chemical modification analysis
###end article-title 146
###begin article-title 147
###xml 45 50 <span type="species:ncbi:9606">human</span>
Target accessibility dictates the potency of human RISC
###end article-title 147
###begin article-title 148
Sequence-specific inhibition of small RNA function
###end article-title 148
###begin article-title 149
Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing
###end article-title 149
###begin article-title 150
siRNAs can function as miRNAs
###end article-title 150
###begin article-title 151
###xml 134 144 134 144 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">C. elegans</named-content>
###xml 134 144 <span type="species:ncbi:6239">C. elegans</span>
The developmental timing regulator AIN-1 interacts with miRISCs and may target the argonaute protein ALG-1 to cytoplasmic P-bodies in C. elegans
###end article-title 151
###begin article-title 152
MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function
###end article-title 152
###begin article-title 153
Molecular mechanisms of translational control
###end article-title 153
###begin article-title 154
Translational control in stress and apoptosis
###end article-title 154
###begin article-title 155
Short RNAs repress translation after initiation in mammalian cells
###end article-title 155
###begin article-title 156
###xml 10 17 <span type="species:ncbi:8355">Xenopus</span>
###xml 31 36 <span type="species:ncbi:9606">human</span>
Xp54, the Xenopus homologue of human RNA helicase p54, is an integral component of stored mRNP particles in oocytes
###end article-title 156
###begin article-title 157
###xml 109 119 109 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
Me31B silences translation of oocyte-localizing RNAs through the formation of cytoplasmic RNP complex during Drosophila oogenesis
###end article-title 157
###begin article-title 158
###xml 67 72 <span type="species:ncbi:9606">human</span>
Co-overexpression of DEAD box protein RCK/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines
###end article-title 158
###begin article-title 159
###xml 50 55 <span type="species:ncbi:9606">human</span>
Overexpression of RCK/p54, a DEAD box protein, in human colorectal tumours
###end article-title 159
###begin article-title 160
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 100 117 <span type="species:ncbi:11103">hepatitis C virus</span>
Overexpression of a DEAD box/RNA helicase protein, RCK/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis
###end article-title 160
###begin article-title 161
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies
###end article-title 161
###begin article-title 162
Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of < 100 A using imaging fluorescence resonance energy transfer
###end article-title 162
###begin title 163
Abbreviations
###end title 163
###begin p 164
###xml 5 6 5 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
2' - O-Methyl
###end p 164
###begin p 165
Argonaute1
###end p 165
###begin p 166
Argonaute2
###end p 166
###begin p 167
cyan fluorescent protein
###end p 167
###begin p 168
enhanced GFP
###end p 168
###begin p 169
fluorescence resonance energy transfer
###end p 169
###begin p 170
green fluorescent protein
###end p 170
###begin p 171
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Photinus pyralis</italic>
###xml 0 16 <span type="species:ncbi:7054">Photinus pyralis</span>
Photinus pyralis luciferase
###end p 171
###begin p 172
microRNA-induced silencing complex
###end p 172
###begin p 173
microRNA
###end p 173
###begin p 174
nucleotide
###end p 174
###begin p 175
mRNA processing body
###end p 175
###begin p 176
RNA-induced silencing complex
###end p 176
###begin p 177
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla reniformis</italic>
###xml 0 18 <span type="species:ncbi:6136">Renilla reniformis</span>
Renilla reniformis luciferase
###end p 177
###begin p 178
RNA interference
###end p 178
###begin p 179
red fluorescent protein
###end p 179
###begin p 180
ribonucleoprotein
###end p 180
###begin p 181
siRNA targeting GFP
###end p 181
###begin p 182
RISC programmed by siRNA
###end p 182
###begin p 183
short interfering RNA
###end p 183
###begin p 184
total cell extract
###end p 184
###begin p 185
yellow fluorescent protein
###end p 185
###begin title 186
Figures and Tables
###end title 186
###begin title 187
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Argonaute Proteins Interact with RCK/p54, a Component of P-Bodies
###end title 187
###begin p 188
(A) Immunoprecipitation and immunoblot analyses. TCEs from HeLa cells co-expressing Myc-Ago2 and YFP-Ago1, YFP-Dcp2, YFP-RCK/p54, YFP-eIF4E, YFP-Lsm1, or YFP were treated with +/- RNase A followed by Myc-Ago2 immunoprecipitation. TCE and anti-Myc IPs were analyzed by immunoblot using anti-GFP and anti-Myc antibodies.
###end p 188
###begin p 189
(B) In vivo localization of RCK/p54 and Ago2 to P-bodies. HeLa cells expressing YFP-Lsm1 and CFP-Ago2 (a, b, and c), YFP-RCK/p54 and CFP-Ago2 (d, e, and f) were visualized by confocal microscopy at 24 h post-transfection.
###end p 189
###begin p 190
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b048">48</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b049">49</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040210-b068">68</xref>
(C) Visualization of interactions between RCK/p54 and Ago2 in P-bodies by FRET. HeLa cells expressing YFP-RCK/p54 and CFP-Ago2 were fixed at 24 h post-transfection. FRET was measured by an acceptor photobleaching method. Fluorescence images of donor (CFP-Ago2) and acceptor (YFP-RCK/p54) molecules were taken before and after photobleaching YFP. FRET efficiencies were calculated as described [ 48, 49, 68], and data were analyzed by Leica confocal software. Arrows point to P-bodies, which are enlarged in insets.
###end p 190
###begin p 191
(D) FRET efficiencies between different P-body protein donor: acceptor pairs. HeLa cells co-expressing YFP-RCK/p54 and CFP-Ago2, YFP-Lsm1 and CFP-Ago2, YFP-RCK/p54 and CFP, YFP-Ago1 and CFP-Ago2, YFP-Ago2 and CFP-Ago1, YFP-RCK/p54 and CFP-Ago-1, as well as YFP-Ago1 and CFP, were fixed and FRET efficiencies were measured.
###end p 191
###begin title 192
###xml 20 25 <span type="species:ncbi:9606">Human</span>
Isolation of Active Human RISC Containing RCK/p54-Ago1/Ago2
###end title 192
###begin p 193
###xml 42 47 <span type="species:ncbi:9606">human</span>
(A) Experimental outline to purify active human RISC. The guide strands of siRNA complexes targeting GFP (si-GFP) were conjugated with 3' biotin (si-GFP-Bi; blue strands) and transfected into HeLa cells. RISCs were captured by incubating cell extracts with streptavidin-magnetic beads.
###end p 193
###begin p 194
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
(B) Target mRNA is cleaved by biotin-captured RISC. Bead (B) and supernatant (S) phases of captured RISC were incubated with 124-nt 32P-cap-labeled GFP target mRNA. The reactions were stopped after 120 min, and products were resolved on 6% denaturing polyacrylamide gels.
###end p 194
###begin p 195
###xml 83 88 <span type="species:ncbi:9606">human</span>
(C) Biotin-captured RISC contains proteins associated with mRNA processing. Active human RISC from HeLa cells expressing Flag-Ago1 was captured by biotin-siRNA and its protein composition was analyzed by immunoblot using anti-Flag, anti-Ago2, anti-RCK/p54, anti-Lsm1, and anti-eIF4E antibodies.
###end p 195
###begin title 196
###xml 26 31 <span type="species:ncbi:9606">Human</span>
RCK/p54 Is a Component of Human miRISC
###end title 196
###begin p 197
###xml 393 395 393 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 494 498 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
###xml 160 166 <span type="species:ncbi:9986">rabbit</span>
###xml 172 178 <span type="species:ncbi:9986">rabbit</span>
###xml 193 199 <span type="species:ncbi:9986">rabbit</span>
(A) Affinity-purified miRISCs associated with PCK/p54 retain cleavage activity. To purify miRISC associated with RCK/p54, magnetic protein A beads coupled with rabbit IgG, rabbit anti-Ago2, or rabbit anti-RCK/p54 antibodies were incubated with HeLa cytoplasmic extracts. After immunoprecipitation, RISC activities were analyzed by incubating the supernatant (S) or bead (B) phases with 182-nt 32P-cap-labeled let-7 substrate mRNAs having a perfectly complementary or mismatched sequence to the let-7 miRNA. Cleavage products were resolved on 6% denaturing polyacrylamide gels. CE, cytoplasmic extract; PM, perfect match; MM, mismatch.
###end p 197
###begin p 198
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 214 216 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 237 239 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 253 256 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
(B) Affinity-purified miRISCs retain cleavage activity. let-7 miRISC cleavage of a perfectly matched RNA target was inhibited by 2'- O-Me oligonucleotides complementary to let-7 miRNA ( let-7-2'- O-Me or let-7-2'- O-Me-biotin). A 182-nt 32P-cap-labeled let-7 substrate mRNA was incubated with the supernatant (S) or bead (B) phases of captured miRISC. The reactions were stopped after 120 min, and products were resolved on 6% denaturing polyacrylamide gels.
###end p 198
###begin p 199
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 218 220 218 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 236 238 236 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
(C) miRISCs contain proteins associated with mRNA processing. Cytoplasmic extracts of HeLa cells expressing Flag-Ago2 and Myc-Ago1 were incubated with 2'- O-Me oligonucleotides complementary to let-7 miRNA ( let-7-2'- O-Me or let-7-2'- O-Me-biotin), affinity-purified by streptavidin-magnetic beads to capture let-7 miRISC. Supernatant (S) and beads (B) after biotin capture were analyzed by immunoblot using anti-Myc, anti-Flag, anti-RCK/p54, and anti-eIF4E antibodies.
###end p 199
###begin title 200
###xml 73 78 <span type="species:ncbi:9606">Human</span>
Depletion of RCK/p54 Disrupts P-bodies and Disperses the Localization of Human Ago2
###end title 200
###begin p 201
###xml 63 68 <span type="species:ncbi:9606">human</span>
HeLa cells were co-transfected with Myc-Ago2 and siRNA against human RCK/p54 (lower panels) or CDK9 mismatch (control; upper panels). At 24 h post-transfection, cells were analyzed by immunofluorescence using antibodies against Myc-Ago2 (A and E) and against the P-body proteins Lsm1 (B and F) and RCK/p54 (C and G). Cells were stained with Hoechst 33258 to visualize nuclei and images were digitally merged (D and H).
###end p 201
###begin title 202
Depletion of Lsm1 Disrupts P-Bodies but Does Not Affect the Interaction between RCK/p54 and Ago2
###end title 202
###begin p 203
(A) Specific knockdown of Lsm1 in HeLa cells by siRNA. HeLa cells were transfected with siRNA against Lsm1 and harvested at 24, 48, and 72 h post-transfection, and TCEs were analyzed by immunoblot with antibodies against Lsm1 or GAPDH.
###end p 203
###begin p 204
(B) Depletion of Lsm1 disrupts P-bodies. HeLa cells were transfected with siRNA against Lsm1. At 48 h post-transfection, cells were analyzed by immunofluorescence using antibodies against Lsm1 and Myc tag for Ago2. Cells were stained with Hoechst33258 to visualize nuclei, and images were digitally merged.
###end p 204
###begin p 205
(C) RCK/p54 interacts with Myc-Ago2 in Lsm1-depleted cells. HeLa cells were transfected for 48 h with Myc-Ago2 and control siRNA or siRNA against Lsm1, TCEs were prepared, and Myc-Ago2 was immunoprecipitated from an aliquot of TCE. TCE and anti-Myc IPs were analyzed by immunoblot using anti-Myc, anti-RCK/p54, and anti-Lsm1 antibodies.
###end p 205
###begin p 206
###xml 499 501 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 515 518 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-</italic>
###xml 271 277 <span type="species:ncbi:9986">rabbit</span>
###xml 283 289 <span type="species:ncbi:9986">rabbit</span>
###xml 304 310 <span type="species:ncbi:9986">rabbit</span>
(D) Affinity-purified RCK/p54 and Ago2 from Lsm1-depleted cell extracts retain miRISC activity. HeLa cells were transfected for 48 h with siRNA against Lsm1, and cytoplasmic extracts were prepared. These extracts were incubated with magnetic protein A beads coupled with rabbit IgG, rabbit anti-Ago2, or rabbit anti-RCK/p54 antibodies to purify miRISC associated with RCK/p54. After immunoprecipitation, RISC activities were analyzed by incubating the supernatant (S) or bead (B) phases with 182-nt 32P-cap-labeled let-7 substrate mRNAs having a perfectly matched or a mismatched sequence to the let-7 miRNA. Cleavage products were resolved on 6% denaturing polyacrylamide gels. MM, mismatch.
###end p 206
###begin title 207
Depletion of RCK/p54 Has No Significant Effect on RNAi Activity In Vivo and In Vitro
###end title 207
###begin p 208
###xml 403 424 403 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
(A) In vivo effect of depleting RCK/p54, Lsm1, and Ago2 on siRNA dose-dependent RNAi activity. HeLa cells were transfected with siRNAs against CDK9 mismatch (control), RCK/p54, Lsm1, or Ago2. 24 h later cells were transfected again with EGFP and RFP reporter plasmids and varying amounts (2, 10, and 50 nM) of siRNA against EGFP. 24 h after the second transfection, RNAi efficiencies were analyzed (see Materials and Methods). To quantify the effect of depleting RCK/p54 and Ago2 on RNAi, the ratio of GFP/RFP signals was normalized to that observed in the absence of GFP siRNA (0 nM). Normalized ratios < 1.0 indicate specific RNAi at a given siRNA concentration.
###end p 208
###begin p 209
###xml 320 341 320 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 449 451 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
(B) Depletion of RCK/p54 has no effect on in vitro siRISC cleavage activity. HeLa cells were transfected with siRNAs targeting RCK/p54, Lsm1, Ago2, or CDK9 mismatch (control). 24 h after the first transfection, cells were again transfected with 50 nM siRNA targeting EGFP. 24 h later cytoplasmic extracts were made (see Materials and Methods), and varying amounts (20, 50, 100 mug) of total cytoplasmic extract protein were incubated with a 124-nt, 32P-cap-labeled GFP target mRNA. The reactions were stopped after 60 min, and products were resolved on 6% denaturing polyacrylamide gels.
###end p 209
###begin p 210
(C) Quantification of siRISC cleavage activity in vitro after depletion of RCK/p54, Lsm1, or Ago2. Cleavage activity of siRISC targeting EGFP mRNA was quantified as a function of protein content in extracts of HeLa cells depleted of RCK/p54, Lsm1, or Ago2.
###end p 210
###begin title 211
RCK/p54 Represses General and miRNA-Mediated Translation
###end title 211
###begin p 212
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 449 451 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 469 490 469 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 530 532 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 644 646 643 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 668 669 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 703 705 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
(A) Release of general translational repression by silencing RCK/p54. Incorporation of [ 35S]methionine into HeLa cells was used to measure general translational activity. Cells were transfected with 50 nM siRNAs targeting mismatched CDK9 (control) or RCK/p54. Mock control cells were treated with the transfection reagent only. At 24 h post-transfection, cells were incubated for 1 h in medium lacking Met and Cys, and metabolically labeled with [ 35S]methionine (see Materials and Methods). As a control for passive uptake of [ 35S], mock cells were treated with 40 mug/ml of the translation inhibitor, cycloheximide. Cell incorporation of [ 35S] is shown as cpm/10 6 cells versus time after adding [ 35S].
###end p 212
###begin p 213
(B) Depletion of RCK/p54 releases translational repression in a luciferase reporter system. HeLa cells were transfected with siRNAs against CDK9 mm (control), RCK/p54, GW182, Lsm1, or Ago2. 24 h later, cells were co-transfected with siRNA (1 x perfectly matched [PM] site) or miRNA (4 x bulged sites) luciferase reporters in the presence of CXCR4 siRNA. RL activities were measured 24 h after the second transfection and normalized to FL activity as a control. Repression of reporter gene expression by siRNA or miRNA were measured by normalizing the RL/FL signals in the presence of CXCR4 siRNA to the RL/FL activities observed in the absence of siRNA. Release of gene repression by siRNA or miRNA is presented as the fold induction of RL/FL activities compared to the RL/FL signals observed in control (si-CDK9mm) experiments. FL, firefly luciferase.
###end p 213
###begin p 214
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 153 155 153 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 175 177 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 303 324 303 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
(C) Depletion of RCK/p54 releases repression of RAS protein translation. HeLa cells were transfected with 100 nM of 2'- O-Me oligonucleotide ( let-7 2'- O-Me inhibitor or 2'- O-Me control), and siRNA against RCK/p54 or CDK9 mm control. 24 h after transfection, the cells were counted and harvested (see Materials and Methods). The protein contents of TCEs were resolved by SDS-PAGE and analyzed by immunoblot using anti-RAS and anti-actin antibodies.
###end p 214
###begin p 215
###xml 139 141 139 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rr</italic>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pp</italic>
###xml 284 286 284 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 307 310 307 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let</italic>
###xml 317 319 317 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 339 341 339 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O-</italic>
###xml 498 500 498 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pp</italic>
###xml 511 513 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rr</italic>
(D) Depletion of RCK/p54 releases repression of luciferase protein translation by 3' UTRs of NRAS and KRAS. HeLa cells transfected with an Rr-luc-expressing vector, pRL-TK, and a Pp- luc-expressing vector, pGL3-control, pGL3-NRAS, or pGL3-KRAS, were co-transfected with 100 nM of 2'- O-Me oligonucleotide ( let-7 2'- O-Me inhibitor or 2'- O-Me control) and siRNA against RCK/p54 or CDK9 mm control. TCEs were prepared 48 h post-transfection and dual luciferase assays were performed. Relative GL ( Pp-luc)/RL ( Rr-luc) signals were normalized to those of pGL3-control-transfected cells and are shown as the fold induction compared to mock treatment.
###end p 215
###begin title 216
###xml 12 17 <span type="species:ncbi:9606">Human</span>
A Model for Human RISC Function Involving miRNA and siRNA
###end title 216
###begin p 217
###xml 389 392 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(n)</italic>
RISC contains Ago2 (red), Ago1 (green), RCK/p54 (blue, labeled p54), and other known (e.g., Dicer and TRBP) and unidentified proteins (pink) and is distributed throughout the cytoplasm. siRISC binds to its target mRNA by perfectly matching base pairs, cleaves the target mRNA for degradation, recycles the complex, and does not require P-body structures for its function. Multiple numbers (n) of miRISC bind to target mRNA by forming a bulge sequence in the middle that is not suitable for RNA cleavage, accumulate in P-bodies, and repress translation by exploiting global translational suppressors such as RCK/p54. The translationally repressed mRNA is either stored in P-bodies or enters the mRNA decay pathway for destruction. Depending upon cellular conditions and stimuli, stored mRNA can either re-enter the translation or mRNA decay pathways.
###end p 217
###begin p 218
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. TMR conceived and designed the experiments. CC performed the experiments. CC and TMR analyzed the data. CC and TMR wrote the paper.
###end p 218
###begin p 219
###xml 58 63 <span type="species:ncbi:9606">human</span>
Citation: Chu C, Rana TM (2006) Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol 4(7): e210. DOI: 10.1371/journal.pbio.0040210
###end p 219
###begin p 220
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported in part by institutional funds and a grant from the National Institutes of Health to TMR.
###end p 220

